Related Experiment Video
Updated: Oct 2, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Increased chemokine gene expression during aging in the murine brain
L K Felzien1, J T McDonald, S M Gleason
1Department of Anatomy and Cell Biology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA. lisa.felzien@rockhurst.edu
Abstract:
Normal aging results in changes in the brain that contribute to the decline of various functions, including learning and memory. Mechanisms causing this decline have not been clearly established. Activation of microglia is associated with the normal aging process in rodents and primates. Microglial activation is regulated by chemokine gene expression, and activated microglia produce substances that can be detrimental to surrounding cells. In this study we determined whether changes in chemokine expression occur during normal aging in the mouse brain. RNA samples taken from the cortex, midbrain, hippocampus, and cerebellum of 4-, 10-, 21- and 30-month-old C57BL6/DBA2 mice were analyzed for changes in gene expression. RNase protection assays were used to examine a panel of chemokines. Increased expression of macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES occurred in all four regions of the brains in the oldest mice. These increases were first detectable at 21 months of age. Increases in MIP-1alpha, MIP-1beta, and RANTES protein levels were also detected in the brains of old mice, as measured by ELISA. Increased microglial activation in the brains of 30-month-old mice, as detected by immunohistochemistry using F4/80 antibodies, correlated with increases in chemokine expression. The observed increases in chemokine gene expression that occur in conjunction with increased microglial activation suggest that chemokines may contribute to the decreased brain function that occurs during normal aging.
Insights
Brain aging leads to cognitive decline. This study found increased chemokine expression and microglial activation in aging mouse brains, suggesting a link to memory loss.
Area of Science:
- Neuroscience
- Immunology
- Aging Research
Background:
- Normal brain aging is associated with functional decline, particularly in learning and memory.
- The underlying mechanisms of age-related cognitive decline remain unclear.
- Microglial activation, a component of the aging process, can produce detrimental substances.
Purpose of the Study:
- To investigate changes in chemokine gene expression during normal aging in the mouse brain.
- To determine if specific chemokines are upregulated in aging brains.
- To correlate chemokine expression with microglial activation.
Main Methods:
- Gene expression analysis (RNase protection assays) of mouse brain regions (cortex, midbrain, hippocampus, cerebellum) at different ages (4, 10, 21, 30 months).
- Protein level quantification using ELISA.
- Immunohistochemistry with F4/80 antibodies to assess microglial activation.
Main Results:
- Significant increases in macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES gene expression were observed in all brain regions of the oldest mice (30 months).
- These chemokine increases were detectable starting at 21 months of age.
- Elevated protein levels of these chemokines and increased microglial activation were confirmed in aged brains.
Conclusions:
- Chemokine gene expression, specifically MIP-1alpha, MIP-1beta, and RANTES, is upregulated during normal mouse brain aging.
- Increased microglial activation correlates with elevated chemokine levels in aging brains.
- These findings suggest that chemokines may play a role in age-related cognitive decline.

